We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNY icon
1826
Alnylam Pharmaceuticals
ALNY
$36.3B
$8K ﹤0.01%
175
CCU icon
1827
Compañía de Cervecerías Unidas
CCU
$2.12B
$8K ﹤0.01%
329
CLH icon
1828
Clean Harbors
CLH
$16.1B
$8K ﹤0.01%
+148
New +$8.19K
CNO icon
1829
CNO Financial Group
CNO
$4.97B
$8K ﹤0.01%
432
+210
+95% +$4.21K
DLB icon
1830
Dolby
DLB
$4.72B
$8K ﹤0.01%
168
+42
+33% +$2.08K
OPLN
1831
Openlane
OPLN
$4.17B
$8K ﹤0.01%
526
HAPN
1832
Happen Inc
HAPN
$2.08B
$8K ﹤0.01%
300
-24
-7% -$682
NVRI icon
1833
Enviri
NVRI
$621M
$8K ﹤0.01%
705
+581
+469% +$7.76K
PCY icon
1834
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$8K ﹤0.01%
+308
New +$8.88K
PRIM icon
1835
Primoris Services
PRIM
$4.69B
$8K ﹤0.01%
372
-880,898
-100% -$21.2M
PSEC icon
1836
Prospect Capital
PSEC
$1.06B
$8K ﹤0.01%
976
RCI icon
1837
Rogers Communications
RCI
$17.7B
$8K ﹤0.01%
191
+162
+559% +$6.79K
RH icon
1838
RH
RH
$3.3B
$8K ﹤0.01%
+175
New +$5.41K
SCHM icon
1839
Schwab US Mid-Cap ETF
SCHM
$14.6B
$8K ﹤0.01%
540
-147
-21% -$2.29K
SIGI icon
1840
Selective Insurance
SIGI
$5.74B
$8K ﹤0.01%
175
-13,460
-99% -$599K
THC icon
1841
Tenet Healthcare
THC
$20.1B
$8K ﹤0.01%
485
-364
-43% -$6.75K
VSH icon
1842
Vishay Intertechnology
VSH
$5.86B
$8K ﹤0.01%
500
ENDP
1843
DELISTED
Endo International plc
ENDP
$8K ﹤0.01%
828
ZNGA
1844
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$8K ﹤0.01%
3,000
MDCO
1845
DELISTED
Medicines Co
MDCO
$8K ﹤0.01%
+183
New +$8.35K
EOCC
1846
DELISTED
Enel Generacion Chile S.A.
EOCC
$8K ﹤0.01%
434
KMG
1847
DELISTED
KMG Chemicals Inc
KMG
$8K ﹤0.01%
179
PGEM
1848
DELISTED
Ply Gem Holdings, Inc.
PGEM
$8K ﹤0.01%
450
XLFS
1849
DELISTED
POWERSHARES S&P SMALLCAP FINANCIALS PORTFOLIO
XLFS
$8K ﹤0.01%
+174
New +$8K
BATRK icon
1850
Atlanta Braves Holdings Series B
BATRK
$3.23B
$7K ﹤0.01%
333
-11
-3% -$235

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.